Page last updated: 2024-09-02

n-(1-methyl-2-phenylethyl)adenosine and pd 98059

n-(1-methyl-2-phenylethyl)adenosine has been researched along with pd 98059 in 1 studies

Compound Research Comparison

Studies
(n-(1-methyl-2-phenylethyl)adenosine)
Trials
(n-(1-methyl-2-phenylethyl)adenosine)
Recent Studies (post-2010)
(n-(1-methyl-2-phenylethyl)adenosine)
Studies
(pd 98059)
Trials
(pd 98059)
Recent Studies (post-2010) (pd 98059)
134044,93931,001

Protein Interaction Comparison

ProteinTaxonomyn-(1-methyl-2-phenylethyl)adenosine (IC50)pd 98059 (IC50)
RAF proto-oncogene serine/threonine-protein kinaseHomo sapiens (human)2.8
Luciferin 4-monooxygenasePhotinus pyralis (common eastern firefly)6.3
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)2.8
Prostaglandin G/H synthase 1Homo sapiens (human)1
Mitogen-activated protein kinase 1Homo sapiens (human)2.8
Dual specificity mitogen-activated protein kinase kinase 2 Rattus norvegicus (Norway rat)4.2
Dual specificity mitogen-activated protein kinase kinase 1 Rattus norvegicus (Norway rat)4.2
Dual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)2.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angulo, E; Canela, EI; Casadó, V; Ferrer, I; Franco, R; Lluis, C; Mallol, J; Viñals, F1

Other Studies

1 other study(ies) available for n-(1-methyl-2-phenylethyl)adenosine and pd 98059

ArticleYear
A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation.
    Brain pathology (Zurich, Switzerland), 2003, Volume: 13, Issue:4

    Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Blotting, Western; Brain; Case-Control Studies; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Flavonoids; Humans; Immunohistochemistry; Indoles; Male; Maleimides; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neuroprotective Agents; Phosphorylation; Receptor, Adenosine A1; Receptors, Adenosine A2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Staining and Labeling; tau Proteins; Time Factors; Translocation, Genetic; Tubulin; Xanthines

2003